By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Cancer Patient’s Social Media Crusade Reaches “Compassionate Use” Victory
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > eHealth > Social Media > Cancer Patient’s Social Media Crusade Reaches “Compassionate Use” Victory
eHealthSocial Media

Cancer Patient’s Social Media Crusade Reaches “Compassionate Use” Victory

Deanna Pogorelc
Deanna Pogorelc
Share
3 Min Read
SHARE

compassionate useOriginally published on MedCityNews.com. The white knight moment has come for a Texas lawyer who has spent the past two months amassing an “army” of virtual supporters in her quest for access to an experimental cancer drug. Only the turnout isn’t exactly as she had imagined.

compassionate useOriginally published on MedCityNews.com. The white knight moment has come for a Texas lawyer who has spent the past two months amassing an “army” of virtual supporters in her quest for access to an experimental cancer drug. Only the turnout isn’t exactly as she had imagined.

Andrea Sloan, who has gathered nearly 210,000 signatures on a petition to BioMarin Pharmaceutical, posted a video on her Facebook page on Thursday expressing gratitude toward her supporters and an unnamed company who she said stepped in to provide her with access to an experimental cancer drug under “compassionate use.”

Sloan had originally reached out to BioMarin requesting access to BMN673, the company’s not-yet-FDA-approved cancer drug which it said shrunk the tumors of 11 out of 25 ovarian cancer patients by at least 30 percent in a recent Phase 1/2 trial. Her doctors had recommended the drug when her ovarian cancer reappeared after several rounds of chemotherapy, two rounds of radiation and five surgeries.

More Read

Here’s How Blockchain Influences The Healthcare Sector
Using Advanced Social Intelligence to Understand the Patient Journey
Tips To Follow To Help Avoid Surprise Medical Bills
Chilly Climates Ideal for Data Center Locations
Prepare Your Healthcare Website for Google’s Mobile-Friendly Algorithm Update

The FDA allows drug companies to give experimental drugs to patients outside of clinical trials if the patient meets certain requirements, which Sloan said she did. But BioMarin had turned down her request, saying in a letter it was “too early to know if the experimental therapy is safe or effective, or will even prolong life.” That was when the social media war began.

In her video, Sloan said a competing pharmaceutical company developing a drug of the same class, a PARP inhibitor, came to the rescue. She said she was now taking a medication that she was sure would help extend her life. The company providing it likely asked for anonymity to avoid being put under a microscope the same way BioMarin was as a result of the campaign.

In a separate video posted on her Facebook, Sloan tells BioMarin that the fight isn’t over. “I did want to let you know that we’re not dead,” she says. “This has always been about compassionate use reform for everyone.”

Day 3 of my new meds…can feel those cancer cells dying. #Grateful Want this for all. #CompassionateUseReform #BioMarinNeedsPolicy

— Andrea Sloan (@andi_sloan) October 6, 2013

 

TAGGED:compassionate use
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

How Setting Boundaries Helps Trauma Survivors Heal
Health
October 30, 2025
how to improve REM sleep
Unlock Better Sleep: How to Improve REM Sleep Naturally
Wellness
October 30, 2025
uv protection in winter
Winter Sun Safety: Why UV Protection Matters Year-Round
Health
October 29, 2025
Nurse Scheduling Software
Evaluating 7 Best Nurse Scheduling Software
Nursing Technology
October 28, 2025

You Might also Like

telehealth
BusinesseHealthMedical RecordsTechnology

Congress Getting Serious about Telemedicine: Are CDOs Ready?

March 28, 2015
eHealthMobile HealthTechnology

How Doctors Can Use Mobile eHealth Apps To Monitor Their Patients

March 19, 2019
Patient Cafe
eHealthMobile HealthSocial Media

Virtual Meet-Ups for Cancer Patients

April 14, 2015

How the IoT Will Improve Patient-Provider Relationships

November 4, 2015
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?